Works matching AU 袁芃

Results: 37

曲妥珠单抗生物类似药 HLX02 与原研药联合帕妥珠单抗及化疗在 HER-2 阳性乳腺癌患者新辅助治疗中的疗效安全性及成本效益比较.

Published in:

Chinese Journal of Oncology, 2025, v. 47, n. 6, p. 517, doi. 10.3760/cma.j.cn112152-20241115-00503

By:

雷紫璇;
桑蝶;
兰波;
樊英;
蔡锐刚;
罗扬;
李俏;
王佳玉;
赵龙妹;
袁芃

Publication type:

Article

基于CNN-Bi-LSTM网络的锂离子电池剩余使用寿命预测.

Published in:

Electric Power Automation Equipment / Dianli Zidonghua Shebei, 2021, v. 41, n. 10, p. 213, doi. 10.16081/j.epae.202110030

By:

梁海峰;
袁芃;
高亚静

Publication type:

Article

晚期乳腺癌二代测序临床应用专家共识 (2024版).

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 12, p. 1127, doi. 10.3760/cma.j.cn112152-20240104-00006

By:

袁芃;
徐兵河

Publication type:

Article

中国晚期三阴性乳腺癌临床诊疗指南 (2024版).

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 6, p. 471, doi. 10.3760/cma.j.cn112152-20240118-00034

By:

袁芃;
徐兵河

Publication type:

Article

利伐沙班预防乳腺癌导管相关血栓前瞻性队列研究中期分析.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 3, p. 256, doi. 10.3760/cma.j.cn112152-20231024-00218

By:

桑蝶;
范善民;
李诗语;
张金涛;
王亨敏;
赵晓慧;
郑利军;
梁平;
郗广彪;
赵龙妹;
张育荣;
袁芃

Publication type:

Article

吉西他滨长疗程维持化疗有助于中国晚期乳腺癌患者生存获益的多中心真实世界研究.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 3, p. 249, doi. 10.3760/cma.j.cn112152-20231024-00251

By:

岳健;
宋国红;
李惠平;
孙涛;
宋丽华;
佟仲生;
张莉莉;
宋振川;
欧阳取长;
杨谨;
潘跃银;
袁芃

Publication type:

Article

抗人表皮生长因子受体 2 抗体药物偶联物在人表皮生长因子受体 2 低表达泛瘤种中的治疗进展.

Published in:

Chinese Journal of Oncology, 2024, v. 46, n. 3, p. 211, doi. 10.3760/cma.j.cn112152-20231024-00227

By:

危彤;
袁芃

Publication type:

Article

乳腺癌铂类药物临床应用专家共识(2023版).

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 12, p. 1018, doi. 10.3760/cma.j.cn112152-20230427-00186

By:

袁芃;
徐兵河

Publication type:

Article

下咽鳞状细胞癌咽后淋巴结转移的临床分析.

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 11, p. 955, doi. 10.3760/cma.j.cn112152-20210630-00117

By:

岳健;
王雪;
朱安婕;
王鼎元;
高崧淋;
胡南林;
司怡然;
郑方超;
巨洁;
王征;
袁芃

Publication type:

Article

程序性死亡蛋白配体1表达状态对早期三阴性乳腺癌患者生存的预测作用.

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 11, p. 948, doi. 10.3760/cma.j.cn112152-20210630-00486

By:

岳健;
王雪;
朱安婕;
王鼎元;
高崧淋;
胡南林;
司怡然;
郑方超;
巨洁;
王征;
袁芃

Publication type:

Article

激素受体阳性人表皮生长因子受体 2 阴性早期乳腺癌术后辅助治疗多基因检测应用专家共识 (2023 版).

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 863, doi. 10.3760/cma.j.cn112152-20230627-00266

By:

袁芃;
徐兵河

Publication type:

Article

DNA 损伤修复变异与三阴性乳腺癌辅助治疗的相关性研究.

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 9, p. 787, doi. 10.3760/ema.j.cn112152-20220912-00612

By:

王雪;
岳健;
康一坤;
高崧淋;
袁芃

Publication type:

Article

紫杉醇 +卡铂密集化疗联合曲妥珠单抗新辅助治疗对比标准辅助治疗对人表皮生长因子受体 2 阳性且激素受体阴性乳腺癌患者生存影响的前瞻性研究.

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 8, p. 709, doi. 10.3760/cma.j.cn112152-20221006-00678

By:

修萌;
陆瑶;
王翔;
樊英;
李俏;
李青;
王佳玉;
罗扬;
蔡锐刚;
陈闪闪;
袁芃;
马飞;
徐兵河;
张频

Publication type:

Article

白蛋白结合型紫杉醇治疗乳腺癌的中国专家共识.

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 3, p. 203, doi. 10.3760/cma.j.cn112152-20230103-00006

By:

袁芃;
徐兵河

Publication type:

Article

紫杉醇脂质体在晚期乳腺癌中应用的真实世界研究.

Published in:

Chinese Journal of Oncology, 2023, v. 45, n. 1, p. 88, doi. 10.3760/cma.j.cn112152-20200622-00069

By:

孙春晓;
王树森;
李健斌;
王永胜;
欧阳取长;
杨谨;
王海波;
王晓稼;
陈文艳;
袁芃;
闫敏;
江泽飞;
殷咏梅

Publication type:

Article

人表皮生长因子受体 2 低表达乳腺癌临床诊疗共识 (2022 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 12, p. 1288, doi. 10.3760/cma.j.cn.112152-20220914-00623

By:

袁芃;
徐兵河

Publication type:

Article

小分子抗血管生成药物治疗晚期乳腺癌超说明书用药专家共识.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 6, p. 523, doi. 10.3760/cma.j.cn112152-20220310-00168

By:

袁芃;
徐兵河

Publication type:

Article

艾立布林治疗晚期乳腺癌疗效和安全性的多中心真实世界研究.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 4, p. 364, doi. 10.3760/cma.j.cn112152-20210226-00173

By:

桑蝶;
宋丽华;
邸立军;
王亚兰;
刘彩刚;
郭仲卿;
刘秋月;
王环;
李诗语;
袁芃

Publication type:

Article

DNA 损伤修复变异指导铂类药物治疗三阴性乳腺癌的应用前景.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 1, p. 68, doi. 10.3760/cma.j.cn112152-20210427-00351

By:

王雪;
岳健;
康一坤;
高崧淋;
袁芃

Publication type:

Article

晚期乳腺癌基因检测热点问题中国专家共识 (2021 版).

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 1, p. 60, doi. 10.3760/cma.j.cn112152-20211111-00837

By:

袁芃;
徐兵河

Publication type:

Article

激素受体阳性人表皮生长因子受体２阴性早期乳腺癌术后辅助治疗多基因检测应用专家共识.

Published in:

Chinese Journal of Oncology, 2022, v. 44, n. 1, p. 54, doi. 10.3760/cma.j.cn112152-20211108-00822

By:

袁芃;
徐兵河

Publication type:

Article

白蛋白紫杉醇治疗晚期乳腺癌疗效和安全性的多中心真实世界研究.

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 10, p. 1114, doi. 10.3760/cma.j.cn112152-20201118-01001

By:

桑蝶;
周华;
宗红;
杨华;
卢芊润;
范善民;
王宇池;
宋丽华;
袁芃

Publication type:

Article

同侧锁骨上淋巴结转移对Ｎ３期乳腺癌预后的影响.

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 10, p. 1069, doi. 10.3760/cma/j.cn112152-20191227-00845

By:

尼露排;
阿布都热黑依木;
王佳玉;
李青;
张频;
马飞;
袁芃;
罗扬;
蔡锐刚;
樊英;
李俏;
陈闪闪;
徐兵河

Publication type:

Article

人表皮生长因子受体２低表达乳腺癌及其相关药物治疗的研究进展.

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 9, p. 901, doi. 10.3760/cma.j.cn112152-20210220-00149

By:

袁芃;
徐兵河

Publication type:

Article

吉西他滨联合奈达铂治疗人表皮生长因子受体 2 阴性晚期乳腺癌的疗效和安全性.

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 8, p. 883, doi. 10.3760/cma.j.cn112152-20200809-00723

By:

岳健;
胡南林;
王雪;
司怡然;
高崧淋;
郑方超;
巨洁;
袁芃

Publication type:

Article

奈拉替尼在激素受体阳性人表皮生长因子受体２阳性乳腺癌治疗中的应用.

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 5, p. 511, doi. 10.3760/cma.j.cn112152-20200410-00329

By:

王雪;
袁芃

Publication type:

Article

铂类药物晚期乳腺癌应用专家共识（2020 版).

Published in:

Chinese Journal of Oncology, 2021, v. 43, n. 2, p. 167, doi. 10.3760/cma.j.cn112152-20201012-00892

By:

袁芃;
徐兵河

Publication type:

Article

聚乙二醇化脂质体多柔比星不良反应管理中国专家共识(2020版).

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 8, p. 617, doi. 10.3760/ema.j.en112152-20200410-00330

By:

袁芃;
徐兵河

Publication type:

Article

年轻乳腺癌患者生育需求现况调查.

Published in:

Chinese Journal of Oncology, 2020, v. 42, n. 5, p. 408, doi. 10.3760/cma.j.cn112152-112152-20191017-00672

By:

巨洁;
张罗欣;
岳健;
朱安婕;
王佳玉;
罗扬;
马飞;
张频;
李青;
袁芃 ;
徐兵河

Publication type:

Article

高复发风险早期乳腺癌患者行表阿霉素联合环磷酰胺序贯紫杉醇剂量密集辅助化的耐受性分析

Published in:

Chinese Journal of Oncology, 2019, v. 41, n. 5, p. 368, doi. 10.3760/cma.j.issn.0253-3766.2019.05.009

By:

王佳妮;
母予馨;
李青;
樊英;
王佳玉;
马飞;
罗扬;
袁芃;
陈闪闪;
李俏;
蔡锐刚;
张频;
徐兵河

Publication type:

Article

POLK基因遗传变异与小细胞肺癌患者铂类药物化疗后的生存相关.

Published in:

Chinese Journal of Oncology, 2019, v. 41, n. 2, p. 112, doi. 10.3760/cma.j.issn.0253-3766.2019.02.007

By:

陈进娜;
封婷;
杨洁;
李洪敏;
袁芃;
马飞;
尹露茜;
林东昕;
徐兵河;
谭文

Publication type:

Article

乳腺癌原发灶和转移灶受体表达的异质性及其临床意义.

Published in:

Chinese Journal of Oncology, 2018, v. 40, n. 7, p. 506, doi. 10.3760/cma.j.issn.0253-3766.2018.07.005

By:

母予馨;
张频;
马飞;
袁芃;
王佳玉;
徐兵河;
李青

Publication type:

Article

DNA 修复基因 RAD52 遗传变异与小细胞肺癌铂类药物化疗疗效的关系.

Published in:

Chinese Journal of Oncology, 2016, v. 38, n. 7, p. 504, doi. 10.3760/cma.j.issn.0253-3766.2016.07.005

By:

李洪敏;
袁芃;
于典科;
马飞;
谭文乐;
封婷;
杨洁;
黄莹;
林东昕;
徐兵河;
谭文

Publication type:

Article

顺铂联合卡培他滨治疗蒽环和紫杉类耐药晚期三阴性乳腺癌的近期疗效与安全性

Published in:

Chinese Journal of Oncology, 2015, v. 37, n. 12, p. 938, doi. 10.3760/cma.j.issn.0253-3766.2015.12.013

By:

李俏;
徐兵河;
李青;
张频;
袁芃;
王佳玉;
马飞;
罗扬;
樊英;
蔡锐刚

Publication type:

Article

长春瑞滨为基础的联合化疗用于蒽环类和紫杉类药物失败后晚期三阴性乳腺癌的疗效及安全性

Published in:

Chinese Journal of Oncology, 2015, v. 37, n. 10, p. 788, doi. 10.3760/cma.j.issn.0253-3766.2015.10.016

By:

杜丰;
袁芃;
罗杨;
王佳玉;
马飞;
蔡锐刚;
樊英;
李青;
张频;
徐兵河

Publication type:

Article

三阴性乳腺癌的治疗进展.

Published in:

Cancer Research on Prevention & Treatment, 2022, v. 49, n. 8, p. 812, doi. 10.3971/j.issn.1000-8578.2022.21.1323

By:

康一坤;
袁芃

Publication type:

Article

哌柏西利治疗HR+/HER2-乳腺癌新进展.

Published in:

Cancer Research on Prevention & Treatment, 2022, v. 49, n. 7, p. 703, doi. 10.3971/j.issn.1000-8578.2022.22.0220

By:

郑方超;
杜丰;
刘昊琳;
王雪;
岳健;
袁芃

Publication type:

Article